BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Yearly performance comparison of index funds helps you rank funds by year, track changes, and refine your allocation strategy today.
19,588 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Poet Technologies stock plummeted today as shares fell in a broad tech rotation. This deep dive explains the main dri...
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...
After years of headwinds, Target is showing early signs of life. Yet the stock price tells a story of cautious optimi...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Showings unveils a no-listing-fee brokerage model that relies on assisting agents and AI to speed listings, betting b...
Alphabet’s growing overlap with NVIDIA is reshaping the AI hardware landscape as Alphabet pushes TPU licenses and NVI...
A transformative era is unfolding as AI reshapes data centers and digital workloads. This article outlines a practica...
ON Semiconductor climbs to fresh highs in 2026 as AI data-center demand and GaN power tech power a strong cash flow-l...
Driven Brands generated $1.9 billion in revenue, signaling a powerful multi-brand approach in the auto aftermarket. B...
Memory industry dynamics are shifting, and Micron stands at the center. This piece breaks down why micron technology ...
Aurora Mobile's Q1 2026 earnings reveal a mix of solid growth and evolving margins. This piece breaks down what the t...